莫西沙星注射液联合痰热清注射液治疗社区获得性肺炎的临床效果观察

The Clinical Efficacy Observation of Tanreqing Injection Combined with Moxifioxacin Injection in Treatment of Community Acquired Pneumonia

目的：观察莫西沙星注射液联合痰热清注射液治疗社区获得性肺炎的临床效果。方法：将92例确诊的社区获得性肺炎患者随机分为治疗组46例和对照组46例，治疗组给予莫西沙星注射液400mg，静脉滴注，另外加用痰热清注射液20ml，2种药物均为每天1次；对照组仅给予莫西沙星注射液400mg，静脉滴注，1次／d。观察比较2组的临床疗效，2组疗程均为7—14天。结果：治疗组和对照组总有效率分别为97．8％和84．8％，2组比较差异显著（P〈0．05）。2组患者均未见明显不良反应。结论：莫西沙星注射液联合痰热清注射液治疗社区获得性肺炎，具有良好的临床疗效，值得临床推广应用。

Objective： To observe the clinical efficacy of Tanreqing injection combined with moxifloxacin injection in the treatment of community acquired pneumonia. Methods： Ninety - two cases of patients with community acquired pneumonia were randomly divided into treatment group and control group, with 46 cases in each group. The treatment group was given Tanreging injection combined with moxi- floxacin injection while the control group was given moxifloxacin injection only, after treatment, the clinical efficacy and the adverse reac- tion were compared between the two groups, two groups^ourse were 7 ~ 14d. Results： The total clinical effective rate was 97.8% in treatment group and 84.8% in control group. There was significant difference between two group in the clinical efficacy （P 〈0.05）. There were no significant adverse reactions. Conclusion： Tanreging injection combined with moxifloxacin injection in the treatment of community acquired pneumonia can achieve good clinical efficacy, and it should be popularized application.